<i>In vitro</i> potency of novel ertapenem/zidebactam combination (WCK 6777) against carbapenemase-producing Enterobacterales collected across India. [PDF]
Bakthavatchalam YD +13 more
europepmc +1 more source
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Multidrug-Resistant <i>Klebsiella pneumoniae</i>: A Retrospective Single-Center Study in China. [PDF]
Yi J +5 more
europepmc +1 more source
Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections. [PDF]
Bradley JS +18 more
europepmc +1 more source
Global epidemiology of carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]
Gottesdiener LS, Satlin MJ.
europepmc +1 more source
Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024. [PDF]
Wise MG +5 more
europepmc +1 more source
Performance evaluation of antimicrobial susceptibility testing methods for ceftazidime-avibactam and imipenem-relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa. [PDF]
Xu X, Lu E, Wu L.
europepmc +1 more source
Phenotypic and biochemical characterization of the class C β-lactamase, PAC-1. [PDF]
Raro OHF +7 more
europepmc +1 more source
Development of a novel LC-MS/MS method for concurrent determination of imipenem, relebactam, and cilastatin in human serum, urine and peritoneal drainage fluid. [PDF]
Yang X +12 more
europepmc +1 more source
Responsible use of new antibiotics for critically ill patients suffering from infections due to carbapenem-resistant organisms-a narrative review for an enablement strategy. [PDF]
Eckmann C +16 more
europepmc +1 more source
Inoculum-dependent activity of contemporary β-lactam agents against carbapenemase- producing Enterobacterales. [PDF]
Sahu TK, Gadkari P, Rathored J.
europepmc +1 more source

